Proteome‐Guided Drug Target Discovery for Periodontitis
Journal of Clinical Periodontology · 2026-01 · 53 (1) · 127-136
DOI: 10.1111/jcpe.70032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 05.09.2025. Verfasst von Zoheir Alayash und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany. Hauptthemen laut MEDLINE: Periodontitis, Proteome, Drug Discovery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).
Abstract (Originalsprache)
Background and Objective Periodontitis is a chronic inflammatory disease driven by immune dysfunction and microbial imbalance. This study aims to identify circulating druggable proteins causally linked to the disease. Materials and Methods We integrated proteomics data from deCODE genetics with periodontitis genome‐wide association studies (GWAS) from the Million Veteran Program to identify proteins associated with periodontitis. Findings were replicated using GWAS data from the Gene‐Lifestyle Interactions in Dental Endpoints consortium. Causal associations were validated using genetic and statistical methods, and the identified proteins were assessed for biological relevance and druggability.
Results
Among the 2088 evaluated proteins, three showed robust evidence of causal association with periodontitis: FGF2 (fibroblast growth factor 2) (odds ratio [OR]: 1.06, 95% confidence interval [CI] 1.032–1.082), AZGP1 (zinc‐alpha‐2‐glycoprotein) (OR: 1.12, 95% CI 1.058–1.189) and BTC (betacellulin) (OR: 0.86, 95% CI 0.789–0.942). Replication analysis confirmed associations for 18 proteins, with 16 showing high colocalisation. Further evaluation of drug target databases revealed indirect links between the identified proteins and approved therapies for inflammatory conditions, suggesting potential therapeutic relevance.
Conclusion
This study identifies three circulating proteins—FGF2, AZGP1 and BTC—as causally associated with periodontitis, highlighting their potential as therapeutic targets. These results provide a foundation for future research into targeted therapies for periodontitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Health Services Research in Dentistry, University of Münster, Münster, Germany.
- Department of Restorative Dentistry, Periodontology, Endodontology, and Preventive and Pediatric Dentistry, University Medicine Greifswald, Greifswald, Germany.
- Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.
- Clinic for Periodontology and Conservative Dentistry, University of Münster, Münster, Germany.
ORCID-Profile: Zoheir Alayash, Sebastian-Edgar Baumeister, Daniel Hagenfeld, Stefan Lars Reckelkamm, Michael Nolde
Förderung
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
Zitieren
APA
Alayash, Z., Baumeister, S. E., Holtfreter, B., Kocher, T., Baurecht, H., Ehmke, B., Hagenfeld, D., Reckelkamm, S. L., & Nolde, M. (2026). Proteome‐Guided Drug Target Discovery for Periodontitis. Journal of Clinical Periodontology, 53(1), 127-136. https://doi.org/10.1111/jcpe.70032
Vancouver
Alayash Z, Baumeister SE, Holtfreter B, Kocher T, Baurecht H, Ehmke B, et al. Proteome‐Guided Drug Target Discovery for Periodontitis. Journal of Clinical Periodontology. 2026;53(1):127-136. doi:10.1111/jcpe.70032
BibTeX
@article{Alayash2026,
author = {Alayash, Zoheir and Baumeister, Sebastian-Edgar and Holtfreter, Birte and Kocher, Thomas and Baurecht, Hansjörg and Ehmke, Benjamin and Hagenfeld, Daniel and Reckelkamm, Stefan Lars and Nolde, Michael},
title = {Proteome‐Guided Drug Target Discovery for Periodontitis},
journal = {Journal of Clinical Periodontology},
year = {2026},
volume = {53},
number = {1},
pages = {127--136},
doi = {10.1111/jcpe.70032}
}
EUVIMED